Novavax Financial Health
Financial Health criteria checks 0/6
Novavax has a total shareholder equity of $-895.6M and total debt of $166.9M, which brings its debt-to-equity ratio to -18.6%. Its total assets and total liabilities are $1.5B and $2.4B respectively.
Debt to equity ratio
|Interest coverage ratio||n/a|
Recent financial health updates
Time To Worry? Analysts Just Downgraded Their Novavax, Inc. (NASDAQ:NVAX) OutlookMar 05
COVID-19 remains global health emergency - WHOOct 19
Novavax spikes ahead of presentations on COVID-19 vaccine portfolioOct 10
US Supreme Court declines to hear challenge of COVID vaccine mandate for health workersOct 03
Novavax makes 1M doses of its COVID-19 vaccine available for use in the UKSep 27
EU clears Novavax's COVID-19 shot for use as a booster dose in adultsSep 12
Novavax wins EU backing for COVID-19 booster shotSep 01
Novavax: Finding Its NicheAug 23
Novavax COVID vaccine gets provisional approval in New Zealand as booster shotAug 17
Novavax Q2: Time To Turn Bullish After The Massive CollapseAug 11
Bearish: Analysts Just Cut Their Novavax, Inc. (NASDAQ:NVAX) Revenue and EPS estimatesAug 11
Novavax COVID-19 shot is linked to rare cases of heart inflammation – EU agencyAug 03
Novavax gets Japanese regulatory nod for use of its COVID vaccine in teensJul 26
Serum Institute of India supplies Novavax's COVID vaccine in USJul 18
Novavax to deliver 3.2M doses of COVID-19 vaccine to U.S.Jul 11
Novavax wins EU nod to use COVID-19 vaccine in adolescentsJul 05
Taiwan to get 504K doses of Novavax COVID vaccine in 1st lot this weekJun 29
Novavax seeks label expansion for COVID-19 shot in CanadaJun 23
The Novavax Vaccine, FinallyJun 08
Is Novavax (NASDAQ:NVAX) Using Debt In A Risky Way?May 24
Novavax: Buying Here Will Not End WellMay 18
Novavax: Don't Catch The Falling KnivesMay 07
Novavax: Management's Revenue Guidance - If It Can Be Trusted - Makes The Bull CaseApr 21
Financial Position Analysis
Short Term Liabilities: NVAX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NVAX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NVAX has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: NVAX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NVAX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NVAX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.1% each year